CHINA SCAR TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 to 2031)

Scarring is a healing process, which occurs after an injury. Its treatment and appearance depends on multiple factors such as the size and depth of the wound. It also depends upon the sex, age, genes and location of the wound. There are various types of scars such as contracture scars, keloid scars, hypertrophic scars, and acne scars. Keloid scars are occurs due to over aggressive healing process. They usually extend beyond their original location of the injury. Treatment of keloid scars include steroid injections, silicone sheets, surgery and others. Contracture scars occur after the skin is burnt. This scar tightens the skin, which impairs the moving ability of the person in that part of the skin. Furthermore, these scars harm muscles and nerves of the injured part. Hypertrophic scars are raised red scars and treatment of these scars include silicon sheets or injection of steroids.

Key features of the study:

• This report provides in-depth analysis of the china scar treatment market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019–2027), considering 2019 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the china scar treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Cynosure, Inc., Syneron Medical Ltd., Mölnlycke Health Care, Ostar Beauty Sci-Tech Co., Ltd., Shanghai Fosun Pharmaceutical Co. Ltd., Beijing Toplaser Technology Co., Ltd., Merz Pharma, and Luca Pharmaceuticals.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The china scar treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the china scar treatment market

Detailed Segmentation:

• China Scar Treatment Market, By Product Type:
  • Topical Scar Products
    • Cream
    • Oil
    • Gel
    • Gel Sheet
    • Elastic Wraps
    • Sprays
  • Aesthetic Lasers
  • Others
• China Scar Treatment Market, By Treatment:
  • Topical
  • Laser
  • Invasive Surgical
  • Others
• China Scar Treatment Market, By Distribution Channel:
  • Hospitals
  • Clinics
  • OTC
• Company Profiles
  • Cynosure, Inc.*
    • Company Overview
    • Material Portfolio
    • Financial Performance
    • Key Highlights
    • Market Strategies
  • Syneron Medical Ltd.
  • Mölnlycke Health Care
  • Ostar Beauty Sci-Tech Co., Ltd.
  • Shanghai Fosun Pharmaceutical Co. Ltd.
  • Beijing Toplaser Technology Co., Ltd.
  • Merz Pharma
  • Luca Pharmaceuticals

“*” marked represents similar segmentation in other categories in the respective section.